tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

LCTX Stock Latest News

Lineage Cell announces 36-month results for Phase 1/2a trial of RG6501
The FlyLineage Cell announces 36-month results for Phase 1/2a trial of RG6501
13h ago
LCTX
Is LCTX a Buy, Before Earnings?
PremiumPre-Earnings
Is LCTX a Buy, Before Earnings?
2d ago
LCTX
Lineage Cell Therapeutics price target lowered to $3 from $4 at B. Riley
PremiumThe Fly
Lineage Cell Therapeutics price target lowered to $3 from $4 at B. Riley
2M ago
LCTX
Optimistic Outlook for Lineage Cell Therapeutics: Buy Rating Supported by Financial Stability and Strategic Developments
PremiumRatings
Optimistic Outlook for Lineage Cell Therapeutics: Buy Rating Supported by Financial Stability and Strategic Developments
2M ago
LCTX
Lineage Cell Therapeutics Faces Uncertainty Amid New U.S. Administration’s Policies
PremiumCompany Announcements
Lineage Cell Therapeutics Faces Uncertainty Amid New U.S. Administration’s Policies
2M ago
LCTX
Lineage Cell Therapeutics’ Earnings Call: Progress Amid Challenges
PremiumCompany AnnouncementsLineage Cell Therapeutics’ Earnings Call: Progress Amid Challenges
2M ago
LCTX
Lineage Cell Therapeutics: 2024 Financial Results and Strategic Progress
Premium
Company Announcements
Lineage Cell Therapeutics: 2024 Financial Results and Strategic Progress
2M ago
LCTX
Options Volatility and Implied Earnings Moves Today, March 10, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 10, 2025
2M ago
FNV
MTN
Options Volatility and Implied Earnings Moves This Week, March 10 – March 14, 2025
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, March 10 – March 14, 2025
2M ago
S
DG
Lineage Cell Therapeutics, Inc. (LCTX) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Lineage Cell Therapeutics, Inc. (LCTX) Q4 Earnings Cheat Sheet
2M ago
LCTX
Lineage Therap Issues Private Placement Securities
PremiumCompany Announcements
Lineage Therap Issues Private Placement Securities
3M ago
LCTX
Promising Advancements in Lineage’s OPC1 Program Boost Investor Confidence
PremiumRatings
Promising Advancements in Lineage’s OPC1 Program Boost Investor Confidence
3M ago
LCTX
Lineage Cell Therapeutics initiates study of OPC1 for spinal injury
PremiumThe FlyLineage Cell Therapeutics initiates study of OPC1 for spinal injury
3M ago
LCTX
Lineage Therap Secures $66M Funding Through Direct Offering
Premium
Company Announcements
Lineage Therap Secures $66M Funding Through Direct Offering
4M ago
8K
LCTX
Lineage Cell Therapeutics price target lowered to $3 from $5 at Maxim
Premium
The Fly
Lineage Cell Therapeutics price target lowered to $3 from $5 at Maxim
4M ago
LCTX
SANA
Lineage Cell price target lowered to $2 from $3 at D. Boral Capital
PremiumThe Fly
Lineage Cell price target lowered to $2 from $3 at D. Boral Capital
4M ago
LCTX
Lineage Cell Therapeutics price target raised to $9 from $7 at H.C. Wainwright
PremiumThe Fly
Lineage Cell Therapeutics price target raised to $9 from $7 at H.C. Wainwright
5M ago
LCTX
Lineage Therap Announces $66 Million Direct Offering
PremiumCompany Announcements
Lineage Therap Announces $66 Million Direct Offering
6M ago
8K
LCTX
Lineage Cell price target lowered to $2 from $3 at D. Boral Capital
PremiumThe Fly
Lineage Cell price target lowered to $2 from $3 at D. Boral Capital
6M ago
LCTX
Lineage Cell Therapeutics initiated with a Buy at D. Boral Capital
PremiumThe FlyLineage Cell Therapeutics initiated with a Buy at D. Boral Capital
6M ago
LCTX
Lineage Cell Therapeutics Reports Q3 2024 Highlights
Premium
Company Announcements
Lineage Cell Therapeutics Reports Q3 2024 Highlights
6M ago
LCTX
Lineage Cell Therapeutics reports Q3 EPS (2c), consensus (3c)
Premium
The Fly
Lineage Cell Therapeutics reports Q3 EPS (2c), consensus (3c)
6M ago
LCTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >